On March 18, 2024, SymBio Pharmaceuticals Limited closed the transaction. The company amended the terms of the transaction and issued 1,350,000 common shares at an issue price of ¥190 per share for the gross proceeds of ¥256,500,000.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
170 JPY | -1.16% | -2.86% | -31.17% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-31.17% | 51.17M | |
+33.43% | 690B | |
+26.43% | 546B | |
-5.12% | 358B | |
+19.59% | 323B | |
+4.89% | 287B | |
+14.32% | 235B | |
+5.79% | 199B | |
-9.49% | 195B | |
+4.26% | 161B |
- Stock Market
- Equities
- 4582 Stock
- News SymBio Pharmaceuticals Limited
- SymBio Pharmaceuticals Limited amended terms of the transaction